AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bls Pharmaceuticals Limited

0.945

+0.0151.61%

Volume:65.46K

Turnover:60.95K

Market Cap:217.33M

PE:23.69

High:0.945

Open:0.930

Low:0.920

Close:0.930

52wk High:0.970

52wk Low:0.760

Shares:229.98M

Float Shares:- -

Volume Ratio:0.36

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.040

EPS(LYR):0.023

ROE:66.14%

ROA:24.99%

PB:10.77

PE(LYR):41.09

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BLS Pharmaceuticals Reports Record Revenue in June Quarter; Fiscal 2026 Revenue Hits Top End of Guidance Range

MT Newswires Live

Australia's BLS Pharmaceutical Soars on Strong Full-year Results

BLS Pharmaceuticals Posts FY26 Adjusted Ebitda of A$19 MLN

Bls Pharmaceuticals - Reports Qtrly Revenue of A$22.5 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BLS.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BLS.AU\",,,,,undefined,":{"symbol":"BLS.AU","market":"AU","secType":"STK","nameCN":"Bls Pharmaceuticals Limited","latestPrice":0.945,"timestamp":1787292720000,"preClose":0.93,"halted":0,"volume":65459,"delay":0,"changeRate":0.01612903225806441,"nameEN":"Bls Pharmaceuticals Limited","floatShares":0,"shares":229978083,"eps":0.039883,"marketStatus":"Closed","change":0.015,"latestTime":"08-21 16:12:00 AEST","open":0.93,"high":0.945,"low":0.92,"amount":60947,"amplitude":0.026882,"askPrice":0.945,"askSize":7027,"bidPrice":0.92,"bidSize":46541,"shortable":3,"etf":0,"ttmEps":0.039883,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.93,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.362413,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BLS.AU","preClose":0.93,"auctionPrice":0.945,"auctionVolume":47,"auctionTime":1787292541468,"referencePrice":0.945,"referenceTime":1787294520280,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292541468}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BLS.AU\",,,,,undefined,":{"symbol":"BLS.AU","floatShares":0,"roa":"24.99%","roe":"66.14%","lyrEps":0.023,"volumeRatio":0.362413,"shares":229978083,"dividePrice":0,"high":0.945,"amplitude":0.026882,"preClose":0.93,"low":0.92,"week52Low":0.76,"pbRate":"10.77","psRate":"4.53","week52High":0.97,"institutionHeld":0,"latestPrice":0.945,"committee":0.737642,"eps":0.039883,"divideRate":0,"volume":65459,"delay":0,"ttmEps":0.039883,"open":0.93,"prevYearClose":0.955,"prevWeekClose":0.94,"prevMonthClose":0.81,"prevQuarterClose":0.955,"fiveDayClose":0.94,"twentyDayClose":0.84,"earningDate":1787673600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"BLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLS.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654409602","title":"BLS Pharmaceuticals Reports Record Revenue in June Quarter; Fiscal 2026 Revenue Hits Top End of Guidance Range","url":"https://stock-news.laohu8.com/highlight/detail?id=2654409602","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654409602?lang=en_us&edition=fundamental","pubTime":"2026-07-27 11:40","pubTimestamp":1785123634,"startTime":"0","endTime":"0","summary":"BLS Pharmaceuticals  reported record quarterly revenue of AU$22.5 million for the three months through June, up 5% from the previous quarter, according to a Monday filing with the Australian bourse.The quarterly sales brought fiscal 2026 revenue to about AU$75 million, 156% above the previous fiscal year and hitting the top end of the company's guidance range, per the filing.The company further reported record fiscal 2026 adjusted earnings before interest, taxes, depreciation, and amortization of AU$19 million, an increase of 190% from the prior year and also at the top end of its guidance range.Additionally, BLS Pharmaceuticals increased its cash balance to AU$13.3 million at the close of June from AU$8.5 million as of March 31.The company's shares gained over 1% in recent Monday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654965920","title":"Australia's BLS Pharmaceutical Soars on Strong Full-year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654965920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654965920?lang=en_us&edition=fundamental","pubTime":"2026-07-27 11:05","pubTimestamp":1785121526,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's BLS Pharmaceutical soars on strongfull-year results** Shares of BLS PharmaceuticalBLS.AXrise as much as 7.1% to A$0.9, set to mark their steepest intraday pct rise since July 13, if t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL6N43T06F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654093251","title":"BLS Pharmaceuticals Posts FY26 Adjusted Ebitda of A$19 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2654093251","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654093251?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:45","pubTimestamp":1785116758,"startTime":"0","endTime":"0","summary":"BRIEF-BLS Pharmaceuticals Posts FY26 Adjusted EBITDA Of A$19 MLNJuly 27 (Reuters)-BLS Pharmaceuticals LtdBLS.AX:REPORTS QTRLY REVENUE OF A$22.5 MILLIONREPORTS FY26 ADJUSTED EBITDA OF A$19 MILLION AT TOP END OF GUIDANCEFurther company coverage:BLS.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43R0E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654067443","title":"Bls Pharmaceuticals - Reports Qtrly Revenue of A$22.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067443","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067443?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:53","pubTimestamp":1785106406,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nFWN43R0E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BLS.AU\",params:#limit:6,delay:true,,,undefined,":[]}}